MedPath

Acupuncture for Analgesia in Transperineal Prostate Biopsy: A Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Prostate Cancer
Pain Management
Acupuncture Analgesia
Prostate Biopsy
Registration Number
NCT06987071
Lead Sponsor
Medipol University
Brief Summary

This randomized controlled trial evaluates the efficacy of acupuncture in reducing pain and improving patient experience during transperineal prostate biopsy. Participants will be randomized to receive either acupuncture or sham acupuncture prior to the biopsy, in addition to standard local anesthesia. The primary outcome is pain, measured using the Visual Analog Scale (VAS), while secondary outcomes include anxiety, additional analgesic use, patient satisfaction, and adverse events.

Detailed Description

Transperineal prostate biopsy is a standard diagnostic procedure for prostate cancer, often associated with pain and anxiety. Although local anesthesia is commonly used, it may not fully alleviate discomfort, and systemic medications can introduce side effects. Acupuncture, a traditional Chinese medicine technique, has demonstrated potential in managing procedural pain and reducing anxiety across various clinical settings. However, its specific efficacy for transperineal prostate biopsy remains underexplored.

This study aims to determine whether acupuncture, administered before the biopsy, can reduce pain, decrease anxiety, and enhance patient satisfaction compared to a sham procedure. Employing a randomized, single-blind design, the trial seeks to minimize bias and generate robust evidence regarding acupuncture's benefits in this context.

Participants will be randomly assigned to either the acupuncture group or the sham acupuncture group, with both receiving standard local anesthesia to ensure ethical care. Pain will be assessed using the Visual Analog Scale (VAS) at multiple time points, and anxiety will be measured with the State-Trait Anxiety Inventory (STAI). Additional outcomes include the use of supplementary analgesics, patient satisfaction, and any adverse events associated with the interventions.

The study's findings could inform clinical practice by introducing a complementary, non-pharmacological option for pain management during transperineal prostate biopsy, potentially improving patient comfort and reducing reliance on systemic medications.

The study protocol has been approved by the Institutional Review Board (IRB) of our hospital, and all participants will provide written informed consent prior to enrollment. Data will be collected and monitored by an independent data manager to ensure accuracy and patient safety.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
110
Inclusion Criteria
  • Indicated for transperineal prostate biopsy (e.g., elevated PSA, abnormal digital rectal exam).
  • Willing and able to provide written informed consent.
Exclusion Criteria
  • Known allergy or contraindication to acupuncture (e.g., bleeding disorder, needle phobia).
  • Requirement for sedation or general anesthesia.
  • Previous experience with acupuncture treatment.
  • Severe psychiatric disorders or diagnosed anxiety disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain ScoreBaseline, perioperative, 30 minutes post-biopsy, 2 hours post-biopsy.

Visual Analog Scale (VAS), a 0-10 scale where 0 represents no pain and 10 represents the worst pain imaginable.

Secondary Outcome Measures
NameTimeMethod
Anxiety Levelbefore and after 30 minutes of operation

State-Trait Anxiety Inventory (STAI), a validated questionnaire.

Additional Analgesic Useafter biopsy in 8 hours

Type and dose of any additional pain medication required.

Adverse eventsperi operative

Any complications related to acupuncture or the biopsy procedure.

Trial Locations

Locations (1)

İstanbul Başakşehir Çam ve sakura City Hospita

🇹🇷

İstanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath